Abstract
A clinical trial was carried out on 20 Parkinsonian patients treated with anticholinergics alone and with the addition of Levodopa-carbidopa. The results show that the association of Levodopa-carbidopa to the anticholinergics sharply improves the therapeutic response of all clinical and functional parameters examined. The combination therapy is well tolerated and easy to titrate.
Original language | English |
---|---|
Pages (from-to) | 436-442 |
Number of pages | 7 |
Journal | Acta Neurologica |
Volume | 33 |
Issue number | 5 |
Publication status | Published - 1978 |
ASJC Scopus subject areas
- Clinical Neurology